$CRBP

$4.12 -$0.13 (3.07%) After hours

$CRBP Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Ownership

13F as of Q2 2026 · 19.3M shares outstanding

Who owns CRBP?

By type of holder

Institutions 69.2% Insiders 24.7% Everyone else 6.1%

Concentration Top 10 holders own 49.7%

Cormorant Asset Management, LP 12.1% · Orbimed Advisors LLC 9.0%

Institutional ownership

69.2%

+2.5 pts vs last qtr

Institutional holders

103

-4 vs last qtr

Net shares bought

+475.0K

by institutions in Q2 2026

New / sold out

22 / 26

positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026

BlackRock, Inc. +1.1M
Jones Hill Capital LP NEW +653.6K

Biggest sellers in Q2 2026

Citadel Advisors LLC −634.9K
Armistice Capital, LLC SOLD OUT −364.0K

Who is planning to sell?

Notices of proposed sale, last 12 months

$1.37M

5 notices from 3 people

Shares covered

78.1K

0.40% of the company

Arranged in advance

81%

of the value is under a 10b5-1 plan

Under a 10b5-1 plan No plan

Largest proposed sellers

Cohen Yuval Officer 10b5-1 $813K
Stifel, Nicolaus & Company, Inc CIAS /FA Officer 10b5-1 $292K

Every notice on Red Flags →

A Form 144 is notice of a planned sale, not the sale itself. What insiders actually sold is on Insider Transactions.

Is your stake being diluted?

Diluted share count, FY2021–FY2025

+225.2%

+34.29% a year

Each share's claim on the business

−69.3%

shrank without buying or selling a share

Spent on buybacks vs paid in stock

— vs $31.1M

over 5 fiscal years

Diluted shares, split-adjusted

Buybacks Stock-based comp

How patient are the owners?

Institutional shares by how long they've been held

5+ years0% 3–5 years23% 1–3 years53% Under 1 year24%

Quarterly turnover

24.3%

of institutional shares changed hands

Top 10 managers, median time held

2.3 years

Super Investors

Investment managers reporting CRBP on Form 13F

Holder	Shares	% of company	Change vs last qtr	Held since	% of their book
CA Cormorant Asset Management, LP	2.3M	12.12%	Unchanged	2024	1.1%
Shares held by quarter Peak holding2.4M (Q3'24) Change over 8 quarters−30.0K Share of the company12.120% Cormorant Asset Management, LP's full portfolio →
OA Orbimed Advisors LLC	1.7M	8.98%	Unchanged	2024	0.3%
Shares held by quarter Peak holding1.7M (Q1'26) Change over 8 quarters+824.7K Share of the company8.980% Orbimed Advisors LLC's full portfolio →

Cormorant Asset Management, LP

2.3M

% of company

12.12%

Change vs last qtr

Unchanged

Held since

2024

Orbimed Advisors LLC

1.7M

% of company

8.98%

Change vs last qtr

Unchanged

Held since

2024

28 more super investors behind a free account

See every manager holding Corbus Pharmaceuticals Holdings, Inc., how their position has changed, and how long they've held it.

Institutional Funds

Mutual funds and ETFs reporting CRBP on Form N-PORT; together they hold 18.0% of the company

Fund	Position value	Shares	% of company	% of the fund	As of
AH abrdn Healthcare Investors abrdn Healthcare Investors	$7.3M	778.0K	4.02%	0.54%	June 30, 2026
AL abrdn Life Sciences Investors abrdn Life Sciences Investors	$5.1M	543.7K	2.81%	0.74%	June 30, 2026

abrdn Healthcare Investors

Position value

$7.3M

% of company

4.02%

% of the fund

0.54%

As of

June 30, 2026

abrdn Life Sciences Investors

Position value

$5.1M

% of company

2.81%

% of the fund

0.74%

As of

June 30, 2026

23 more funds behind a free account

See every fund holding Corbus Pharmaceuticals Holdings, Inc. and how much of the fund the position is.

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G

Holder	Shares	% of company	Change vs last qtr	8 quarters	Held since	% of their book
MS Moran Sean F. Insider	48.6K	0.25%	—	—	—	—
Insider holdings come from Form 3/4/5 filings, which are not quarterly. Share of the company0.250% Moran Sean F.'s insider activity →
CY Cohen Yuval Insider	7.2K	0.04%	—	—	—	—
Insider holdings come from Form 3/4/5 filings, which are not quarterly. Share of the company0.040% Cohen Yuval's insider activity →

Moran Sean F.

Insider

48.6K

% of company

0.25%

Change vs last qtr

—

Held since

—

Cohen Yuval

Insider

7.2K

% of company

0.04%

Change vs last qtr

—

Held since

—

2 more holders behind a free account

See every insider and 5%+ holder of Corbus Pharmaceuticals Holdings, Inc..

Comments